u/source_or_silence

This is correct. Hypo risk is real.

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

no tracking numbers, no full addresses, no label photos — instant removal

Which country?

Adding to this: A1c is doing more work than the comment implies.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

How many weeks between the two measurements?

Maintenance for 11 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.

Did you actually measure heart rate or is that a feeling?

Yes, exactly this, and it is the bit that took me 34 weeks to accept.

Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.

Did you actually measure heart rate or is that a feeling?

stalled at 2.4mg, went up, and regretted it, the stall would have broken anyway

Came off after 36 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

pentadecapeptide is sequence, the supply chain naming is a mess

Strongly agree. The regain is expected.

no "told you so" comments, removed without discussion

Respectfully this is a sample of one presented as a finding.

the regulatory rodent evidence is solid, human evidence is not

the logger trace is the data that matters, not the packaging promises

Crossposting this to c/compounding because the people who need it are not reading this community.